VBIVQ — VBI Vaccines Share News
0.000.00%
Last trade - 00:00- $0.01m
- $36.16m
- $8.68m
VBI Vaccines Inc reports results for the quarter ended in June - Earnings Summary
Brief: VBI Vaccines Inc - $82.4 Million In Cash At End Of Q2 2022
VBI Vaccines Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Vbi Vaccines Inc Received Notice Of Delisting From Nasdaq
U.S. STOCKS ON THE MOVE-Moderna Inc, Nike Inc, Mustang Bio
U.S. STOCKS ON THE MOVE-Kraft Heinz Co, Coinbase, Altria Group
VBI Vaccines rises on 'orphan drug' tag for vaccine candidate
Brief: VBI Vaccines Receives U.S. FDA Orphan Drug Designation For Vbi-1901 For The Treatment Of Glioblastoma
Brief: VBI Vaccines Presents Updated Phase 2A Tumor Response And Overall Survival Data For Vbi-1901
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Reports First Quarter 2022 Financial Results
VBI Vaccines Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Carmax, Blue Apron, Intevac, Redbox Entertainment
U.S. STOCKS ON THE MOVE-Blue Apron, Moderna, Redbox, OppFi
Brief: VBI Vaccines Announces European Commission Marketing Authorisation For Prehevbri
VBI Vaccines Inc up on EU nod for hepatitis B vaccine
U.S. STOCKS ON THE MOVE-PVH, Aterian, First Solar
U.S. STOCKS ON THE MOVE-System1, Domino's Pizza, Sunshine Biopharma
VBI Vaccines rises as COVID-19 drug shows promise